The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Tags · Sourcing

research use only

Material not approved for human use, sold for laboratory research.

56 topics 18 solved Group: Sourcing

Related in this group: certificate of analysis · batch & lot numbers · Janoshik Analytical · Medutest · PeptideMeter · VendorInvestigate · third-party testing · blind sampling · documentation quality · underdosing · mislabelling · customs

56 topics · page 1 of 2

TopicParticipantsRepliesViewsActivity
Compounds this community declines to help with, and why — does this still hold?
Compounds this community declines to help with, and why — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen SCALE ( N Engl J Med ,…
TGAVGDAT+3 7 26k 7h
What a regulator's shortage notice actually authorises
What a regulator's shortage notice actually authorises — that is the question, and I have not found it answered plainly anywhere I have looked. A logistics question, since the answers here are usually better…
BESCAAQLSG+8 12 15k 17h
AOD-9604 and the fragment hypothesis, revisited — does this still hold?
The question in the title: AOD-9604 and the fragment hypothesis, revisited — does this still hold? I will give what I have already checked below so nobody repeats it. Comparing FLOW ( N Engl J Med , 2024)…
NLKKNRPFI+7 11 31k 19h
Research-use-only status: what it means legally and practically
Research-use-only status: what it means legally and practically Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024) cited in…
KFKLVSHVAF+72 81 44k 1d
Follow-up: How compounding permissions changed when supply normalised
How compounding permissions changed when supply normalised I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion, following the…
STNHSLSTJM+72 77 1.5k 1d
Why chargeback is not the safety net people assume
Asking directly, because I could not find a straight answer: Why chargeback is not the safety net people assume A logistics question, since the answers here are usually better than anywhere else I have…
TNEDFLILBW+22 26 2.5k 2d
Why catalogue breadth is not evidence of anything
Why catalogue breadth is not evidence of anything I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURPASS-4 ( Lancet , 2021) cited in support of a claim I…
CBKAV 2 38k 2d
Coming back to: Payment method and the leverage it gives you, ranked
Payment method and the leverage it gives you, ranked — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked…
NRDWZVGLAP+21 26 43k 2d
[2026 update] Currency conversion and the cost you did not see
Posting this under the heading it deserves: Currency conversion and the cost you did not see Everything below is what sits behind that. A logistics question, since the answers here are usually better than…
TVLCASFPVT+21 26 52k 2d
Prescription requirements and telehealth models — a second dataset
On the subject in the title: Prescription requirements and telehealth models — a second dataset Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…
MOLAPFPHB+87 94 1.1k 21d
Naming conventions for research peptides and the confusion they cause
Posting this under the heading it deserves: Naming conventions for research peptides and the confusion they cause Everything below is what sits behind that. Comparing STEP 8 ( JAMA , 2022) with STEP 1 ( N…
ATNFPNDA+21 25 4.9k 22d
Documenting a payment dispute without naming and shaming — the long version
Posting this under the heading it deserves: Documenting a payment dispute without naming and shaming — the long version Everything below is what sits behind that. I would like to talk about documentation…
MAQZIL 2 32k 1mo
Labelling requirements for research chemicals — the long version
Posting this under the heading it deserves: Labelling requirements for research chemicals — the long version Everything below is what sits behind that. I would like to talk about documentation quality as a…
LSDBHK 2 1.8k 2mo
Documenting a payment dispute without naming and shaming
Documenting a payment dispute without naming and shaming — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal, separately from…
ESKOKFCBL+5 9 9.8k 2mo
Currency conversion and the cost you did not see
Currency conversion and the cost you did not see — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked for.…
ELSGLE 2 44k 2mo
Second pass at: Why chargeback is not the safety net people assume
Second pass at: Why chargeback is not the safety net people assume Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually…
DBMMHB 2 25k 3mo
Why this community will not facilitate a group purchase
Asking directly, because I could not find a straight answer: Why this community will not facilitate a group purchase A logistics question, since the answers here are usually better than anywhere else I have…
RMMPLS 2 40k 3mo
A payment that went through twice: how it was resolved
A payment that went through twice: how it was resolved Writing it up because I had to work it out twice and would rather nobody else did. I would like to talk about documentation quality as a signal,…
RJASVBSDSB+20 24 55k 3mo
Why a compound being unapproved is not the same as being illegal to possess
Why a compound being unapproved is not the same as being illegal to possess I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion,…
LCFNJBSCAN+72 78 23k 3mo
About the Regulatory category
Research-use-only status, compounding rules, import restrictions, and the primary documents behind them. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
OBSLKEFNV 4 49k 4mo
Labelling requirements for research chemicals
Labelling requirements for research chemicals — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked for.…
BNCGCCMLNN+5 9 45k 4mo
Second pass at: What to keep a record of at the point of payment
Second pass at: What to keep a record of at the point of payment — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better than…
RSCVDSIAOO+14 18 1.9k 4mo
Research-use-only labelling: what it means and what it does not
Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not Everything below is what sits behind that. I would like to talk about documentation quality as a…
ZNPPJENGGR+100 110 37k 5mo
Coming back to: Reading a supplier's product description as a marketing document
Reading a supplier's product description as a marketing document Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited in…
HBELCVHNDN+35 39 688 5mo
AOD-9604 and the fragment hypothesis, revisited
Posting this under the heading it deserves: AOD-9604 and the fragment hypothesis, revisited Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med , 2021) with SUSTAIN 6 ( N Engl J Med…
ARCDJBMRBR+40 44 2.8k 6mo
Coming back to: Payment mechanics and the recovery options that do not exist
On the subject in the title: Payment mechanics and the recovery options that do not exist Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers…
ZSSSLKDEK+7 11 2.6k 7mo
Prescription requirements and telehealth models
Prescription requirements and telehealth models Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than anywhere…
MBNHKDWV+91 97 5.4k 7mo
What a regulator's shortage notice actually authorises — what changed since
The question in the title: What a regulator's shortage notice actually authorises — what changed since I will give what I have already checked below so nobody repeats it. A logistics question, since the…
JMMBUCRVW+22 26 53k 7mo
About the Other compounds category
Anything not covered by a dedicated subcategory, including research-use-only material with no human data. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
KJMMYSDK+8 12 51k 7mo
Pharmaceutical compounding rules, summarised from primary sources — a second dataset
Posting this under the heading it deserves: Pharmaceutical compounding rules, summarised from primary sources — a second dataset Everything below is what sits behind that. A logistics question, since the…
CRDPICCDJB+50 56 780 8mo